cinoxacin has been researched along with nalidixic acid in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (74.36) | 18.7374 |
| 1990's | 2 (5.13) | 18.2507 |
| 2000's | 5 (12.82) | 29.6817 |
| 2010's | 3 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Black, HR; Elliott, RA; Kesler, P; Redlich, LR; Szwed, JJ; Yu, PL | 1 |
| Barnham, M; Gaya, H | 1 |
| Izumi, T; Kitagawa, T | 1 |
| Izumi, T; Kitagawa, T; Nagayama, T | 1 |
| Björnegård, B; Brorson, JE; Trollfors, B; Zackrisson, G | 1 |
| Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL | 2 |
| Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH | 1 |
| Barba, D; Esposito, S; Galante, D; Pennucci, C | 1 |
| Grimm, H | 1 |
| Forth, W | 1 |
| Smith, JT | 1 |
| Piccolomini, R; Ravagnan, G; Renzini, G; Russo, G; Speciale, AM | 1 |
| Tenney, JH; Warren, JW | 1 |
| Ottrad, M; Shah, PM; Stille, W | 1 |
| Vuye, A | 1 |
| Heessen, FW; Muytjens, HL | 1 |
| Ottnad-Walz, M; Shah, PM; Stille, W | 1 |
| Barry, AL; Jones, RN | 2 |
| Ayers, LW; Barry, AL; Gerlach, EH; Jones, RN; Sommers, HM; Thornsberry, C | 1 |
| Leigh, DA; Marriner, J; Smith, EC | 1 |
| Burt, RA | 1 |
| Chantrie, M | 1 |
| Bucy, JG | 1 |
| Paulson, DF | 1 |
| Briedigkeit, H; Buder, R; Dröseler, H; Precht, K; Schimmelpfennig, R | 1 |
| Drylie, DM | 1 |
| Mendoza-Díaz, G; Moreno-Esparza, R; Perez-Alonso, R | 1 |
| Durán Merás, I; Galeano Díaz, T; Rodriguez Cáceres, MI; Salinas López, F | 1 |
| Chiang, CH; Lu, DW; Tai, MC | 1 |
| Holzgrabe, U; Kiefer, W; Neugebauer, U; Popp, J; Schmitt, M; Szeghalmi, A | 1 |
| Romero, IC; Saravia, NG; Walker, J | 1 |
| Cárdenas, YM; Cordero, T; Díaz, Y; Fuentes, A; Gómez, L; Izzo, C; López, V; Ortega, J; Ramirez, A; Rivas, C; Vargas, F; Zoltan, T | 1 |
| Katritzky, AR; Khelashvili, L; Kovacs, J; Munawar, MA | 1 |
6 trial(s) available for cinoxacin and nalidixic acid
| Article | Year |
|---|---|
Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.
Topics: Aged; Amoxicillin; Anti-Infective Agents, Urinary; Cinoxacin; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Urinary Tract Infections | 1984 |
Review of adverse reactions associated with cinoxacin and other drugs used to treat urinary tract infections.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents, Urinary; Central Nervous System Diseases; Cinoxacin; Clinical Trials as Topic; Drug Combinations; Drug Hypersensitivity; Gastrointestinal Diseases; Humans; Middle Aged; Nalidixic Acid; Nitrofurantoin; Pyridazines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
A clinical comparison of cinoxacin and nalidixic acid in the treatment of urinary tract infection.
Topics: Adult; Central Nervous System Diseases; Cinoxacin; Clinical Trials as Topic; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Nalidixic Acid; Pyridazines; Recurrence; Urinary Tract Infections | 1981 |
Comparison of cinoxacin and nalidixic acid in patients with cystitis.
Topics: Adult; Aged; Cinoxacin; Cystitis; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Nalidixic Acid; Pyridazines | 1982 |
[A comparison of cinoxacin and nalidixic acid in the treatment of chronic urinary tract infections].
Topics: Bacteriuria; Chronic Disease; Cinoxacin; Cystitis; Gastrointestinal Diseases; Humans; Nalidixic Acid; Nervous System Diseases; Pyelonephritis; Pyridazines; Urinary Tract Infections | 1982 |
Cinoxacin and nalidixic acid in treatment of urinary tract infections.
Topics: Bacterial Infections; Cinoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Pyridazines; Urinary Tract Infections | 1981 |
33 other study(ies) available for cinoxacin and nalidixic acid
| Article | Year |
|---|---|
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Partition of cinoxacin and nalidixic acid in canine vascular and extravascular compartments.
Topics: Animals; Body Fluids; Cinoxacin; Dogs; Female; Lymph; Male; Nalidixic Acid; Pyridazines; Time Factors | 1979 |
In vitro susceptibility of urinary isolates of Escherichia coli to cinoxacin.
Topics: Cinoxacin; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Pyridazines; Urinary Tract Infections | 1979 |
Protein binding of quinolonecarboxylic acids. I. Cinoxacin, nalidixic acid and pipemidic acid.
Topics: Animals; Blood Proteins; Cinoxacin; Dialysis; Dogs; Humans; In Vitro Techniques; Nalidixic Acid; Nicotinic Acids; Pipemidic Acid; Protein Binding; Pyridazines; Rats; Species Specificity | 1989 |
Protein binding of quinolonecarboxylic acids. II. Spectral changes on the interaction of cinoxacin, nalidixic acid and pipemidic acid with human and rat albumins.
Topics: Animals; Cinoxacin; Humans; Nalidixic Acid; Nicotinic Acids; Pipemidic Acid; Pyridazines; Rats; Serum Albumin; Spectrophotometry, Ultraviolet; Spectrum Analysis | 1989 |
Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin.
Topics: Amdinocillin; Anti-Bacterial Agents; Bordetella pertussis; Cinoxacin; Doxycycline; Imipenem; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Rifampin; Thienamycins | 1985 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica | 1985 |
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae | 1985 |
Comparative in vitro studies with 4-quinolone antimicrobials.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1985 |
Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
Topics: Bacteriuria; Cinoxacin; Ciprofloxacin; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pipemidic Acid; Quinolines | 1985 |
[In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
Topics: Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas aeruginosa; Quinolines; Topoisomerase II Inhibitors | 1985 |
[Gyrase inhibitor].
Topics: 4-Quinolones; Anti-Bacterial Agents; Bacteria; Cinoxacin; Drug Resistance, Microbial; Humans; Nalidixic Acid; Ofloxacin; Oxazines; Pipemidic Acid; Quinolines; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1985 |
Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Topics: 4-Quinolones; Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fluoroquinolones; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1986 |
In vitro synergistic activity of some chinolinic compounds combined with beta-lactam antibiotics against gram-positive and gram-negative clinical isolates.
Topics: Amoxicillin; Cefadroxil; Cephalexin; Cinoxacin; Drug Synergism; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Pyridazines | 1985 |
Bactericidal activity of norfloxacin and nine other urinary tract antibiotics against Gram-negative bacilli causing bacteriuria in chronically catheterized patients.
Topics: Anti-Infective Agents, Urinary; Bacteria; Bacteriuria; Catheterization; Cinoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin | 1983 |
In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
Topics: Anti-Bacterial Agents; Bacteria; Cinoxacin; Enterobacter; Escherichia coli; Humans; Klebsiella pneumoniae; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Pipemidic Acid; Pyridazines; Serratia marcescens | 1983 |
In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
Topics: Anti-Bacterial Agents; Cinoxacin; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Oxolinic Acid | 1983 |
In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Cinoxacin; Ciprofloxacin; Humans; Nalidixic Acid; Norfloxacin; Pipemidic Acid; Quinolines | 1984 |
In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
Topics: Agar; Anti-Bacterial Agents; Bacteria; Cinoxacin; Culture Media; Humans; Nalidixic Acid; Nicotinic Acids; Norfloxacin; Pipemidic Acid; Pyridazines; Urine | 1983 |
Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
Topics: Acinetobacter; Anti-Infective Agents, Urinary; Bacteria; Cinoxacin; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae; Enterococcus faecalis; Escherichia coli; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pseudomonas; Pseudomonas aeruginosa; Quality Control; Reference Standards; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
Topics: Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Micrococcaceae; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Quinolines | 1984 |
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
Topics: Anti-Bacterial Agents; Bacteria; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Nalidixic Acid; Naphthyridines; Norfloxacin; Oxolinic Acid; Pseudomonas aeruginosa; Quinolines | 1984 |
[Cinobar, a new antimicrobial agent for the treatment of urinary infections].
Topics: Adult; Cinoxacin; Escherichia coli Infections; Female; Humans; Male; Nalidixic Acid; Pyridazines; Random Allocation; Urinary Tract Infections | 1980 |
Stability constants of copper(II) mixed complexes with some 4-quinolone antibiotics and (N-N) donors.
Topics: Anti-Infective Agents; Cinoxacin; Copper; Kinetics; Models, Chemical; Nalidixic Acid; Organometallic Compounds | 1996 |
Determination of the chemotherapeutic quinolonic and cinolonic derivatives in urine by high-performance liquid chromatography with ultraviolet and fluorescence detection in series.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Cinoxacin; Humans; Nalidixic Acid; Oxolinic Acid; Pipemidic Acid; Piromidic Acid; Sensitivity and Specificity; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 1997 |
Corneal and scleral permeability of quinolones--a pharmacokinetics study.
Topics: Administration, Topical; Animals; Aqueous Humor; Cell Membrane Permeability; Cinoxacin; Ciprofloxacin; Conjunctiva; Cornea; Enoxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Rabbits; Sclera; Time Factors; Water | 2003 |
Vibrational spectroscopic characterization of fluoroquinolones.
Topics: Aza Compounds; Cinoxacin; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Enoxacin; Enzyme Inhibitors; Fluoroquinolones; Hydrogen Bonding; Hydrogen-Ion Concentration; Models, Chemical; Models, Molecular; Models, Theoretical; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxolinic Acid; Quinolines; Quinolones; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Temperature; Ultraviolet Rays; Vibration; Water | 2005 |
Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro.
Topics: Animals; Cell Line; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Leishmania guyanensis; Macrophages; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones | 2005 |
Synthesis, primary photophysical and antibacterial properties of naphthyl ester cinoxacin and nalidixic acid derivatives.
Topics: Anti-Bacterial Agents; Cell Survival; Cinoxacin; Escherichia coli; Hydroxyl Radical; Nalidixic Acid; Naphthalenes; Naphthyridines; Oxygen; Reactive Oxygen Species | 2008 |
Synthesis of amino acid derivatives of quinolone antibiotics.
Topics: Amino Acids; Anti-Bacterial Agents; Cinoxacin; Fluoroquinolones; Nalidixic Acid; Oxolinic Acid; Quinolines; Triazoles | 2009 |